Archive for the "Trade-mark Oppositions" Category

Royal Assent Received for Most Recent Amendments to Canada’s IP Legislation

Posted by Neil Melliship on December 21st, 2018

Bill C-86, the Budget Implementation Act, 2018 (the “Act”), received Royal Assent on December 13, 2018, after moving through Parliament at a blistering pace. In all, less than two months elapsed between the tabling of the bill and its passage. These amendments will affect the Trade-marks Act, the Patent Act and the Copyright Act.  In [...]

TwitterFacebookLinkedInInstapaperShare
View the full post »

Parliament Tables Proposed Amendments to the Trade-marks Act

Posted by Neil Melliship on October 31st, 2018

On October 29, 2018, the Canadian Parliament tabled, in a surprise to many practitioners, the Budget Implementation Act 2 (Bill C-86), which would amend, among other things, the Patent Act, Trade-marks Act, and Copyright Act. In addition, the bill contains provisions enacting the College of Patent and Trade-mark Agents Act . Proposed amendments to the Trade-marks [...]

View the full post »

What’s Your Evidence? The Danger of Hearsay Evidence in IP Litigation

Posted by Andrew Dixon on July 27th, 2016

In Pfizer Canada Inc. v. Teva Canada Limited, 2016 FCA 161, the Federal Court of Appeal (“FCA”) recently overturned a substantial damages award in a pharmaceutical patented medicines action on the basis that the trial judge admitted improper hearsay evidence. This is an important reminder that the hearsay rule of evidence is alive and well. [...]

View the full post »